Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6. This change is a backend revision with no impact on the visible study details.SummaryDifference0.0%

- Check20 days agoChange DetectedNew recruitment sites and investigators were added to the study record, expanding listed locations and contacts. An NIH grant/contract entry was added, and an existing investigator entry was removed.SummaryDifference0.1%

- Check34 days agoChange DetectedNew recruitment sites and contacts were added, including Hospital Santa Izabel in Salvador, Brazil (Clarissa Mathias) and KLES Dr. Prabhakar Kore Hospital & Medical Research Centre (Rohan Bhise), along with associated investigators and phone numbers; older entries for these sites were removed or updated.SummaryDifference0.1%

- Check55 days agoChange DetectedThe site revision has been updated to v3.6.4, replacing v3.6.3, indicating a backend/UI update without changing the study details presented on the page.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Fundacao Pio XII - Hospital de Barretos (Barretos, Brazil) with Josiane Mourao Dias at site 007-457 and phone +55 1733 216600; added Universitatsklinikum Augsburg with Bjorn Hackanson at site 007-2222 and phone +498214002729; added Local Institution 007-743-Ph3; updated Primary Completion date to 2028-10-31 and Study Completion date to 2029-10-31 with a Completed status. Removed prior site records and contacts for Xinjiang Medical University Cancer Hospital - Urumqi, Site 007-457, Site 007-2222, and associated not-yet-recruiting/contacts.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision tag was bumped from v3.6.2 to v3.6.3, indicating a small update to the page's content or metadata.SummaryDifference0.0%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.